CADILA HEALTHCARE LTD. - 532321 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Dhaval N SoniDesignation :- Company Secretary and Compliance Officer CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus CADILA HEALTHCARE LTD. - 532321 - Disclosure Under Regulation 23(9)
Disclosure under regulation 23(9) for related party transactions for half year ended on March 31, 2020 on consolidated basis CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus'' receives supplemental Abbreviated New Drug Application (sANDA) approval from the USFDA for manufacturing of Doxycycline Injection at Jarod, Vadodara Coronavirus vaccine: Zydus Cadila, Bharat Biotech start trials; Moderna enters final phase
Coronavirus vaccine news update: Moderna has said that its experimental COVID-19 vaccine has shown that it is safe and provokes immune responses in all 45 health volunteers in an early-stage study CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives final approval from USFDA for Betamethasone Dipropionate Ointment CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus starts the Human Dosing for Adaptive Phase I ⅈ clinical trials' CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate CADILA HEALTHCARE LTD. - 532321 - Shareholding for the Period Ended June 30, 2020
Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here CADILA HEALTHCARE LTD. - 532321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate for the quarter ended on June 30, 2020.